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Abstract
Treatment the Apert Syndrome is unique, therefore, divergences exist 
in the priority of the procedures performed by each team. The Apert 
Syndrome occurs in approximately 1/65,000 births and accounts for 
4.5% of all craniosynostosis. Some changes in Apert Syndrome stand 
out, such as craniosynostosis and polydactyly.
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Apert Syndrome is the most widely recognized craniosynostosis syn-
drome. It was first described by Wheaton’ in 1894 and subsequently 
further cases were reported by Apert. Apert syndrome, named af-
ter this French physician "Eugene Apert" who first described it in 
1906 and is a relatively uncommon cranio-facial anomaly. [1] It oc-
curs in approximately 1/65,000 births and accounts for 4.5% of all 
craniosynostosis [2, 3]. In case of an affected parent, the condition 
is transmitted in an autosomal dominant way with the offspring of 
one affected parent heterozygous for the mutation. [4] Most cases 
of AS are caused by either one of the two missense mutations in 
FGFR2 exon 7, i.e., C934G or C937G leading to the amino acid subs-
titutions S252W or P253R, respectively. These mutations are known 
to enhance ligand-dependent activation of FGFR2 by reducing the 
dissociation rate between ligands and FGFR2; loss of ligand specificity 
in turn causes aberrant binding of FGFR2IIIc, a mesenchymal splicing 
isoform, to FGF7 or FGF10, thereby inducing enhanced differentiation 
of osteoblasts. [5, 6, 7, 8].
The typical clinical features of Apert syndrome described extensively 
in the literature include: 1) Craniosynostosis: a wide bony defect pos-
sibly extending from glabella to the posterior fontanel and caused by 
the early closure of the coronal suture, the cranial base and the abs-
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ence of the sagittal and metopic sutures; 2) Midface 
hypoplasia: as the fronto-ethmoidal suture, spheno-
occipital and spheno-ethmoidal synchondroses fuse 
early, both the anterior and posterior parts of the 
cranial base are short and give rise to hypoplasia of 
the midface. This is the case in the transverse as well 
as in the sagittal direction, which result in a skeletal 
Class III relationship; 3) Cone-shaped calvarium; 4) 
Skeletal open bite: a large anterior open bite is pre-
sent in most patients, along with a Class III maloc-
clusion and retruded maxillary teeth; 5) Pharyngeal 
attenuation: this is also the result of early synostosis 
of the spheno-occipital synchondrosis, resulting in 
a short posterior cranial base and thus reduction of 
the pharyngeal height; 6) Pseudocleft palate with 
a Byzantine-arch shape: the bilateral swellings of 
the palatine processes create a midline pseudocleft 
of the soft tissue; 7) Dental findings: delayed tooth 
eruption, ectopic eruption of teeth, shovel-shaped 
incisors, tooth agenesis and severe crowding; 8) 
Ocular manifestations: proptosis (often asymmetric), 
hypertelorism and shallow orbitae. Patients often 
experience visual disturbances which are due to 
imbalance of the muscles that move the eyes; 9) 
Syndactyly of hands and feet, or webbing of the fin-
gers and toes: the fused digits are usually separated 
surgically; however, there can be limited mobility 
of some fingers due to progressive ossification of 
interphalangeal joints; 10) Mild intellectual disabi-
lity may be present in some individuals; 11) Cuta-
neous manifestations: excessive sweating is a typical 
characteristic; 12) Gastrointestinal and cardiac mal-
formations may be present in patients with Apert 
syndrome; 13) Impaired hearing: hearing loss can 
occur due to recurrent ear infections; 14) Unusual 
speech characteristics: underdevelopment of the 
midface, a small nose and an excessively long soft 
palate can lead to hyponasal resonance. If patients 
also have a cleft palate, however, then hypernasal 
resonance will be produced. Speech and language 
development is also often affected when hearing is 
impaired. [9-14, 4].
Surgical treatment requires a team approach 
consisting of neuroradiologist, craniofacial sur-
geon, pediatric surgeon, pediatric anesthetist, 
plastic surgeons for hand surgery and orthodon-
tist. [15, 1].
Treatment of each patient is unique, therefore, 
divergences exist in the priority of the procedures 
performed by each team. Some changes in Apert 
Syndrome stand out in search term, such as cra-
niosynostosis and polydactyly.
Craniosynostosis
In 1971, Tessier described the use of the frontofa-
cial advancement to correct the deformity of the 
Apert skull. His frontofacial advancement was fur-
ther modified by Ortiz-Monasterio in 1978 into the 
monobloc osteotomy, which advanced the orbits 
and the midface together. Van der Meulen used 
this monobloc to correct orbital hypertelorism in a 
child with a median facial cleft, and Tessier refined 
this to the facial bipartition. [16-18, 19].
The ultimate goals of treatment for craniosy-
nostosis are relieving cranial constriction to allow 
functional brain development and improving or 
maintaining cosmetic appearance. Various surgi-
cal techniques such as frontoorbital advancement 
(FOA) or total calvarial reconstruction have been 
described for treating craniosynostosis, which are 
standard procedures for craniosynostosis because 
of their postoperative effects on the cranial vault. 
[20-23, 24]
The incidence of relapse is low when syndromic 
craniosynostosis is treated with monobloc distrac-
tion or Le Fort III midfacial distraction. These pro-
cedures are recognised as useful surgical techniques 
that can yield good morphological and functional 
results and that can replace conventional methods. 
According to past reports, each institution seems to 
be using an external or internal device for distrac-
tion based on the surgeon’s preference. The exter-
nal and internal devices appear to be used at even 
frequencies. However, it is not easy to appropriately 
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differentiate their uses, and selection of device type 
is often a challenge. [25].
The present study used three types of devices in 
patients according to an algorithm that we develo-
ped ourselves (Figure 1). [25]
Distraction techniques with a variety of external 
and internal distraction systems have been suc-
cessfully used to advance the midface. However, 
external distraction devices generally cannot deliver 
adequate distraction forces for lengthening; as a re-
sult, the distraction achieved is limited. On the other 
hand, internal distraction devices do not allow con-
trol of the post fixation distraction vector. We have 
developed a hybrid facial distraction system (HFDS) 
leveraging the advantages of external and internal 
distractiondevices. However, when the advanced 
maxilla undergoes excessive clockwise rotation and 
is shifted more downward vertically than the plan-
ned position, it might be impossible to pull it back 
into the planned position (Figure 2). [26-35, 36].
In many craniofacial units, a posterior vault ex-
pansion is done as initial surgery in patients with 
Apert and Crouzon syndromes and craniofrontona-
sal dysplasia. The conventional technique for poste-
rior vault expansion needs a large dural dissection 
compared to the spring technique to release the 
Figure 1: Algorithm of Early Le Fort III Distraction in Craniosynostosis. [25].
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Figure 2:  External distraction devices enabling control of distraction vertical vector and maxillary dis-
traction technique with internal and external devices. A, Before procedure. B, Orbital and 
facial height increased by excessive clockwise rotation of distraction. C, Adequate orbital 
and facial height achieved by vertical distraction device. D and E, The external distraction 
device enables control of the distraction vector via surgical wires. At the same time, the 
internal distraction device has an adjustable angle which moves up and down according 
to the direction of the wires. The angle of the internal distraction device’s fixation position 
on the temporal bone can be altered by 5–15 degrees from side to side. Additionally, the 
device which can control the direction of the advanced maxilla vertically is attached to the 
external distraction device. Then, surgical wires are attached to the screws and spindle 
units after penetrating through the scalp and passed through the inside of the zygomatic 
arch. The vertical direction of the extended maxilla can be controlled by adjustment of the 
spindle units. [36].
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dura from the bone flap; this involves a higher risk 
for significant blood loss. Furthermore, the amount 
of push back of the occiput is restricted by the tight-
ness of the skin. These problems have been solved 
with the introduction of distraction osteogenesis-
assisted vault expansion. The current technique with 
internal distractors that protrude through skin inci-
sions has some disadvantages such as pin infection 
and mechanical problems. Spring-assisted posterior 
vault expansion is a possible alternative. Spring-as-
sisted expansion was introduced by Lauritzen et al. 
and has since been used for various indications and 
types of craniosynostosis. [37-46, 47]. 
However, calvarial distraction is not without po-
tential downsides: enlargements are limited to a 
single vector per device, the treatment process is 
extended from a single day to a number of months, 
and second operative procedures are necessary 
for removal of the expansion devices. Issues with 
expansion devices have also been reported inclu-
ding mechanical breakage and erosion of springs 
through the bone. [48, 49, 50]. It is thought that 
posterior vault expansion offers a greater volume 
increase compared to frontal vault expansion, pre-
serves the facial profile in case of midface hypo-
plasia, and leaves the frontal part of the skeleton 
untouched which may reduce the complications of 
a monobloc or facial bipartition performed at a later 
age. A monobloc or facial bipartition is indicated 
in most cases to protect the eyes in case of severe 
exorbitism, treat obstructive sleep apnea, and for 
aesthetic reasons. [51, 47]
Our team developed an advancement method 
using an external transfacial pin and limited osteoto-
mies on the external orbit. No Le Fort III osteotomy 
was used and the gap between the nose and the 
skullbase was in this way avoided. 
As a consequence, our actual technique did not 
allow us to correct significantly the anterior open 
bites, but we did not generate new ones either. On 
the other hand, it allows to control the distraction 
vector and to correct it easily in case of disturban-
ces. The disadvantage of using external devices resi-
des especially in their social aspect as the child may 
be stigmatized during this period by his peers and 
may not be suitable for school classes over 3 to 6 
weeks. The anterior scar of the external wires can 
be between 0.5 and 1.5 cm long. It can be treated 
as a scar revision if needed. The other advantages 
of an external frame are numerous. The procedure 
is simple and fast, the frame is easily inserted and 
removed at the end of the protocol in the day of 
surgery. It is less distressing than the halo frame. 
There has no risk for intracranial accidental penetra-
tion of our device when performing complete vault 
reshaping. The limited osteotomies and the lack of 
Le Fort osteotomy avoids communication to the 
cranial fossa and potential severe complications like 
infection and CSF leakage. There is also no bleeding 
from a facial osteotomy. Furthermore, the use of an 
external device avoids the risk of infection related 
to intra-focal devices. [52-55, 56].
Polydactyly
The main goal of surgery for hand anomalies of 
Apert syndrome patients is to reconstruct the 
thumb to index finger pulp-topulp pinch to over-
come common difficulties in their daily life such 
as holding a fork or a spoon and buttoning up. 
[57, 58]. Various classifications have been used to 
assist surgeons in planning surgery. The Upton [60] 
classification is most commonly used; it divides the 
hand deformity into 3 types that correspond with 
increasing severity. Type 1 consists of a complex 
(osseous and soft-tissue) syndactyly of digits 2 
through 5, with the thumb free. This is described 
as the spade hand. A type 2 deformity involves a 
complex syndactyly of digits 2 through 5, with an 
associated simple syndactyly of the thumb. This 
has been described as the spoon or mitten hand. 
A type 3 deformity consists of complex syndactyly 
of digits 1 through 5, with complex syndactyly of 
the thumb; it has been described as the rosebud 
hand. [59-61, 62]
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We have developed a protocol for preoperative 
imaging of the Apert hand that enables visuali-
zation of the arterial anatomy to a level distal to 
the distal interphalangeal joints (Figure 3). This 
information is used by the surgeon to plan and 
execute a single-stage syndactyly release of the 
entire hand, which reduces the total number of 
operations a child must have. We were able to 
manipulate 3-dimensional reconstructions of the 
angiograms to allow operative planning (Figure 
3). The images were then analyzed to identify at 
least one artery to each digit, demonstrating con-
tinuity of contrast material. The position of these 
arteries was recorded, and surgical dissection was 
planned to ensure that each artery was included 
in the correct digit. Abnormalities in the anatomy 
were identified and incorporated into the surgical 
plan. [62].
A single-stage release of the syndactyly provides 
the benefit to the patient of a single operation and 
a single recovery period, this means noteworthy 
savings in terms of hospital bills and accommoda-
tion expenses, in addition to the obvious benefit of 
fewer operations. recovery period. For many of our 
patients who travel from overseas and remain in our 
center during the. [62].
 After the initial procedures for syndactyly release, 
when the fact that the range of motion is limited in 
the second proximal interphalangeal joint is taken 
into consideration, radial deviation of the thumbs 
remains as the most important issue for Apert syn-
drome patients in terms of functional impairment. 
Because radial deviation of the thumb is associated 
with the loss of index-to-thumb pulp-to-pulp pinch, 
these patients may experience limitations in their 
daily life activities such as problems in buttoning up 
and holding a spoon. [63, 58].
In this study, instead of the conventional linear 
approach, a C-shaped osteotomy was performed 
from radial to ulnar direction to the distal portion 
of the triangular delta phalanx with care to spare 
the epiphyseal plate. Planning a C-shaped osteo-
tomy allows the desired rotation while distracting 
the segments. Moreover, because bone-to-bone 
contact is not lost and the segments are gliding 
on each other during distraction, we believe that 
the risk for fibrous union is lower and the obtained 
bone quality is better than with the conventional 
approach. An external fixator is placed using 1 or 2 
pins to the proximal portion and 1 pin to the distal 
side of the osteotomy with care, sparing the epiphy-
seal plate (Figure 4). In patients whose delta phalanx 
was hypoplastic, for insertion of proximal pins, the 
Figure 3:  Representative images of the 3-dimen-
sional angiograms of the Apert hand 
deformity. Angiograms of A, B type 1, 
C type 2, and D type 3 apert hands. [62]
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distal portion of the first metacarpal bone was pre-
ferred. Pin loosening seems to be the major disad-
vantage of our procedure because this led to loss 
of stability of the external fixator in 6 applications 
of 4 patients. Besides pin loosening in 2 patients, 
PTI was observed. Another potential disadvantage 
of distraction is subluxation of the adjacent joint, 
whereas in the long-term follow-up, this had not 
been seen in any of our patients. This is probably 
related to the distraction and adaptation of the soft 
tissue as well. [58]
Possible Treatment In The Future?
Fibroblast growth factor receptors (FGFR) 1–4 are 
members of the tyrosine kinase receptor family, 
and thus far 22 FGF ligands have been identified. 
FGFR signaling induces proliferation, migration, di-
fferentiation, and survival of many cell types. Apert 
syndrome is characterized by craniosynostosis and 
severe bony syndactyly of the hands and feet. It 
is predominantly caused by missense mutations in 
FGFR2, which lead to S252W or P253R amino acid 
substitutions and result in a gain-of-function FGF 
signaling. [64-66, 67].
Recently, two independent mouse models of 
Fgfr21/S252W and Fgfr21/P253R have been established. 
Similar to AS patients, both models exhibit prema-
ture coronal suture (CS) fusion, midfacial hypoplasia, 
and a domed skull. [68-70, 74].
These mouse models are used to evaluate novel 
targets and strategies for treatment of Apert Syn-
drome. The MEK1 inhibitor PD98059 was shown to 
reduce CS fusion in calvarial explants from Fgfr21/
P253R mice. Both pre- and post-natal administration 
of the MEK1/2 inhibitor U0126 inhibited AS-like 
phenotypes in Fgfr21/S252W male mice, as did gene 
therapy to express a short hairpin RNA against the 
Fgfr21/S252W allele. However, synostosis resumed af-
ter withdrawal of the chemical inhibitor, which re-
flects the postoperative re-synostosis phenomenon 
frequently observed in syndromic craniosynostosis 
patients. Inhibitors of other pathways that promote 
osteoblastic differentiation may provide alternatives 
for direct inhibition of FGF signaling, but they have 
not been evaluated in an Apert mouse model. [69, 
71, 72, 74].
Our previous study demonstrated that a soluble 
form of the Apert mutant FGFR2 (sFGFR2IIIcS252W), 
which lacks the transmembrane and cytoplasmic 
domains, acted as a decoy receptor by competing 
for ligand binding with FGFRs. This mutant inhi-
bited enhanced osteoblastic differentiation in the 
Figure 4:  A, Schematic of preoperative appearance demonstrating brachydactyly and radial angulation 
of the thumb. B, Schematic of intraoperative appearance; note the C-shaped osteotomy per-
formed to the distal portion of the triangular delta phalanx with care to spare the epiphyseal 
plate. C, Schematic of postoperative appearance; the correction of radial angulation and 
lengthening of the thumb are remarkable. [58]
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MG63 osteosarcoma cell line transfected with FG-
FR2IIIcS252W. Furthermore, calvarial osteoblasts de-
rived from FGFR2IIIcS252W transgenic mice prolife-
rated and differentiated via highly activated MEK, 
ERK, and p38 pathways, whereas these pathways 
were suppressed in calvarial osteoblasts expressing 
sFGFR2IIIcS252W. [67, 73, 74].
Our purified sFGFR2IIIcS252W is unique for several 
reasons. First, we speculate that soluble FGFR2IIIc-
S252W can spread to the whole body through the 
bloodstream because of its endogenous expression 
in human tissues. Second, it has potent inhibitory 
effects towards the pathological conditions of Apert 
because of the S252W mutation, which causes loss 
of ligand specificity and reduces ligand dissociation 
rates; this study is the first to report the use of a so-
luble receptor carrying a mutation associated with 
a human congenital anomaly. Third, purified sFG-
FR2IIIcS252W not only has binding affinity for Fgf2, 
but was also shown to dimerize with membrane-
bound or cytoplasmic monomeric FGFR2 in the pre-
sence or absence of the S252W mutation, resulting 
in incomplete dimers that block subsequent inter-
cellular signaling. [74]
Our current strategy, which applied the purified 
protein to the calvarial tissue by using a nanogel-
crosslinked hydrogel system as the protein carrier 
has several advantages; individual nanogels can sto-
re proteins inside their nano spaces and then gra-
dually release proteins locally without any signifi-
cant change in their biological activities; they do not 
contain antigens; they are inexpensive. However, 
many problems must be resolved before this pro-
tein is applied in clinical settings for the treatment 
of Apert patients. Because craniosynostosis typically 
occurs during fetal life, the safety and effectiveness 
of FGFR2-based treatment must be tested and an 
appropriate administration technique should be es-
tablished using animal experiments in vivo. Some 
patients with craniosynostosis display recrudescence 
of bony fusion just after craniectomy; the complex 
might help block these unfavorable phenomena 
caused by aberrant FGF/FGFR signaling. Taken to-
gether, our data suggested that the appropriate 
delivery of purified sFGFR2IIIcS252W could be an 
effective method for treating not only AS but also 
other types of craniosynostosis resulting from abe-
rrant FGF/FGFR signaling. [75, 74]
References
 1. Saritha S, Supriya G, Kumar MP. Apert syndrome 
(Acrocephalosyndactyly): a case report. Int J Res Med Sci. (2013); 
1(1): 36-40. 
 2. Cohen MM, Jr., Kreiborg S, Lammer EJ, Cordero JF, Mastroiacovo 
P, Erickson JD, Roeper P, Martinez-Frias ML. 1992. Birth 
prevalence study of the Apert syndrome. Am J Med Genet 42: 
655–659.
 3. Morita J, Nakamura M, Kobayashi Y, Deng CX, Funato N, 
Moriyama K.Soluble Form of FGFR2 With S252W Partially 
Prevents Craniosynostosis of the Apert Mouse Model. Dev Dyn.. 
(2014); 243: 560–567.
 4. Carpentier S, Schoenaers J, Carels C, Verdonck A. Cranio-
maxillofacial, orthodontic and dental treatment in three patients 
with Apert syndrome. Eur Arch Paediatr Dent. (2014); 15: 281–
289.
 5. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, et 
al. (1995) Apert syndrome results from localized mutations of 
FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165–
172.
 6. Yu K, Herr AB, Waksman G, Ornitz DM (2000) Loss of fibroblast 
growth factor receptor 2 ligand-binding specificity in Apert 
syndrome. Proc Natl Acad SciUS A 97: 14536–14541.
 7. Yang F, Wang Y, Zhang Z, Hsu B, Jabs EW, et al. (2008) The 
study of abnormal bone development in the Apert syndrome 
Fgfr2+/S252W mouse using a 3D hydrogel culture model. Bone 
43: 55–63.
 8. Yokota M, Kobayashi Y, Morita J, Suzuki H, Hashimoto Y, et al. 
Therapeutic Effect of Nanogel-Based Delivery of Soluble FGFR2 
with S252W Mutation on Craniosynostosis. PLoS ONE. (2014); 
9(7): e101693.
 9. Kreiborg S, Cohen MM Jr. Characteristics of the infant Apert 
skull and its subsequent development. J Craniofac Genet Dev 
Biol. 1990; 10: 399–410.
 10. Avantaggiato A, Carinci F, Curioni C. Apert’s syndrome: 
cephalometric evaluation and considerations on pathogenesis. 
J Craniofac Surg. 1996; 7: 23–31.
 11. Vadiati Saberi B, Shakoorpour A. Apert syndrome: report of 
a case with emphasis on oral manifestations. J Dent (Tehran). 
2011; 8:90–95.
InternatIonal archIves of MedIcIne
Section: cranio-Maxillofacial Surgery 
Issn: 1755-7682 
2015
Vol. 8 No. 87
doi: 10.3823/1686
© Under License of Creative Commons Attribution 3.0 License 9
 12. Letra A, de Almeida AL, Kaizer R, et al. Intraoral features of 
Apert’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod. 2007; 103: 38–41.
 13. Cohen MM Jr, Kreiborg S. The central nervous system in the 
Apert syndrome. Am J Med Genet. 1990; 35: 36–45.
 14. Cohen MM Jr, Kreiborg S. Cutaneous manifestations of Apert 
syndrome. Am J Med Genet. 1995; 58: 94–6.
 15. Holten IW, Bourne AJ. The Apert syndrome hand: pathologic 
anatomy and clinical manifestations. Plast Reconstr Surg 1997; 
96: 1681-7. 
 16. van der Meulen JC. Medial faciotomy. Br J Plast Surg 1979 Oct; 
32(4):339e42 [PubMed PMID: 534804. Epub 1979/10/01. eng].
 17. Tessier P. Apert’s syndrome: acrocephalosyndactyly type I. In: 
Caronni EP, editor. Craniofacial surgery. Boston: Little Brown; 
1985. pp. 280e303.
 18. Allam KA, Wan DC, Khwanngern K, et al. Treatment of Apert 
syndrome: a long-term follow-up study. Plast Reconstr Surg 
2011 Apr; 127(4): 1601e11 [PubMed PMID: 21187805. Epub 
2010/12/29. eng].
 19. Crombag GA, Verdoorn MH, Nikkhah D, Ponniah AJ, Ruff C, 
Dunaway D. Assessing the corrective effects of facial bipartition 
distraction in Apert syndrome using geometric morphometrics. 
J Plast Reconstr Aesthet Surg. (2014); 67: e151-e161
 20. Lo LJ, Marsh JL, Yoon J, Vannier MW. Stability of fronto-orbital 
advancement in nonsyndromic bilateral coronal synostosis: a 
quantitative three-dimensional computed tomographic study. 
Plast Reconstr Surg 1996;98:393e405 [discussion 406e409].
 21. Wong GB, Kakulis EG, Mulliken JB. Analysis of fronto-orbital 
advancement for Apert, Crouzon, Pfeiffer, and Saethre-Chotzen 
syndromes. Plast Reconstr Surg 2000; 105: 2314e23.
 22. Lwin CT, Richardson D, Duncan C, May P. Relapse in frontoorbital 
advancement: a pilot study. J Craniofac Surg 2011 Jan; 22(1): 
214e6.
 23. Kim YO, Choi JW, Kim DS, et al. Cranial growth after distraction 
osteogenesis of the craniosynostosis. J Craniofac Surg 2008; 19: 
45e55.
 24. Yamaguchi K, Imai K, Fujimoto T, Takahashi M, Maruyama Y, 
Sakamoto H, Matsusaka Y. Cranial distraction osteogenesis for 
syndromic craniosynostosis: long-term follow-up and effect on 
postoperative cranial growth. J Plast Reconstr Aesthet Surg. 
(2014); 67(2): e35-41.
 25. Mitsukawa N, Kaneko T, Saiga A, Akita S, Satoh K. Early 
midfacial distraction for syndromic craniosynostotic patients 
with obstructive sleep apnoea. J Plast Reconstr Aesthet Surg. 
(2013); 66(9): 1206-11.
 26. Britto JA, Evans RD, Hayward RD, et al. Maxillary distraction 
osteogenesis in Pfeiffer’s syndrome: urgent ocular protection by 
gradual midfacial skeletal advancement. Br J Plast Surg. 1998; 
51: 343–349.
 27. Chin M, Toth BA. Le Fort III advancement with gradual distraction 
using internal devices. Plast Reconstr Surg. 1997; 100: 819–830; 
discussion 831.
 28. Molina F, Ortiz Monasterio F, de la Paz Aguilar M, et al. Maxillary 
distraction: aesthetic and functional benefits in cleft lip-palate 
and prognathic patients during mixed dentition. Plast Reconstr 
Surg. 1998; 101: 951–963.
 29. Polley JW, Figueroa AA. Management of severe maxillary 
deficiency in childhood and adolescence through distraction 
osteogenesis with an external, adjustable, rigid distraction 
device. J Craniofac Surg. 1997; 8: 181–185; discussion 186.
 30. Swennen G, Colle F, De May A, et al. Maxillary distraction in 
cleft lip palate patients: a review of six cases. J Craniofac Surg. 
1999; 10: 117–122.
 31. Cohen SR. Craniofacial distraction with a modular internal 
distraction system: evolution of design and surgical techniques. 
Plast Reconstr Surg. 1999; 103: 1592–1607.
 32. Gosain AK, Santoro TD, Havlik RJ, et al. Midface distraction 
following Le Fort III and monobloc osteotomies: problems and 
solutions. Plast Reconstr Surg. 2002; 109: 1797–1808.
 33. Cohen SR. Midface distraction. Semin Orthod. 1999; 5: 52–58.
 34. Polley JW, Figueroa AA. Rigid external distraction: its 
applicationin cleft maxillary deformities. Plast Reconstr Surg. 
1998; 102: 1360–1372; discussion 1373.
 35. Kobayashi S, Nishiouri T, Maegawa J, et al. A novel craniofacial 
osteogenesis distraction system enabling control of 
distraction distance and vector for the treatment of syndromic 
craniosynostosis. J Craniofac Surg. 2012; 23: 422–425.
 36. Kobayashi S, Fukawa T, Hirakawa T, Maegawa J. A Osteogenesis 
Distraction Device Enabling Control of Vertical Direction for 
Syndromic Craniosynostosis. Plastic and Reconstructive Surgery 
Global Open. (2014); 2(2): e113.
 37. Arnaud E, Marchac A, Jeblaoui Y, Renier D, Di Rocco F (2012) 
Spring-assisted posterior skull expansion without osteotomies. 
Childs Nerv Syst 28(9): 1545–1549.
 38. Davis C, Lauritzen CG (2009) Frontobasal suture distraction 
corrects hypotelorism in metopic synostosis. J Craniofac Surg 20 
(1): 121–124.
 39. Davis C, MacFarlane MR, Wickremesekera A (2010) Occipital 
expansion without osteotomies in Apert syndrome. Childs Nerv 
Syst 26(11): 1543–1548.
 40. Lauritzen C, Sugawara Y, Kocabalkan O, Olsson R (1998) Spring 
mediated dynamic craniofacial reshaping. Case report. Scand J 
Plast Reconstr Surg Hand Surg 32(3): 331–338.
 41. Lauritzen CG, Davis C, Ivarsson A, Sanger C, Hewitt TD (2008) 
The evolving role of springs in craniofacial surgery: the first 100 
clinical cases. Plast Reconstr Surg 121(2): 545–554.
 42. Nowinski D, Saiepour D, Leikola J, Messo E, Nilsson P, Enblad P 
(2011) Posterior cranial vault expansion performed with rapid 
distraction and time-reduced consolidation in infants with 
syndromic craniosynostosis. Childs Nerv Syst 27(11): 1999–
2003.




Vol. 8 No. 87
doi: 10.3823/1686
This article is available at: www.intarchmed.com and www.medbrary.com 10
 43. Serlo WS, Ylikontiola LP, Lahdesluoma N, Lappalainen OP, 
Korpi J, Verkasalo J, Sandor GK (2011) Posterior cranial vault 
distraction osteogenesis in craniosynostosis: estimated increases 
in intracranial volume. Childs Nerv Syst 27(4):627–633.
 44. Steinbacher DM, Skirpan J, Puchala J, Bartlett SP (2011) Expansion 
of the posterior cranial vault using distraction osteogenesis. 
Plast Reconstr Surg 127(2): 792–801.
 45. Swennen G, Schliephake H, Dempf R, Schierle H,Malevez C 
(2001) Craniofacial distraction osteogenesis: a review of the 
literature: part 1: clinical studies. Int J Oral Maxillofac Surg 30(2): 
89–103.
 46. White N, Evans M, Dover MS, Noons P, Solanki G, Nishikawa 
H (2009) Posterior calvarial vault expansion using distraction 
osteogenesis. Childs Nerv Syst 25(2): 231–236.
 47. de Jong T, van Veelen ML, Mathijssen IM.  Spring-assisted 
posterior vault expansion in multisuture craniosynostosis. Childs 
Nerv Syst. (2013) May;29(5):815-20.
 48. Davis C, Windh P, Lauritzen CG. Do expansile cranial springs 
erode through the cranium? J Craniofac Surg 2009; 20: 168–
170. PubMed PMID: 19165018. Epub 2009/01/24. Eng.
 49.  Lee JA, Park DH, Yoon SH, et al. Distractor breakage in cranial 
distraction osteogenesis for children with craniosynostosis. 
Pediatr Neurosurg 2008;44:216–220. PubMed PMID: 18354261.
 50. Fearon JA1, Varkarakis GM, Kolar J. A comparative study of 
anterior cranial vault distraction versus remodeling. J Craniofac 
Surg. (2014) Jul; 25(4): 1159-63.
 51. Sgouros S, Goldin JH, Hockley AD, Wake MJ (1996) Posterior 
skull surgery in craniosynostosis. Childs Nerv Syst 12(11): 727– 
733
 52. Pellerin P, Capon-Degardin N, Martinot-Duquennoy V, Vinchon 
M, Dhellemmes P (2001) Mid-facial distraction without 
osteotomy with a trans-facial pin report of 4 clinical cases. Ann 
Chir Plast Esthet 46(4): 277–284
 53. Coeugniet E, Dhellemmes P, Vinchon M, Wolber A, Pellerin 
P (2012) Midfacial distraction without osteotomy using a 
transfacial pin and external devices. J Craniofac Surg 23(1): 
184–189
 54. Yu CJ, Fearon J, Havlik RJ, Buchman SR, Polley JW (2004) 
Distraction osteogenesis of the craniofacial skeleton. Plast 
Reconstr Surg 114(1): 1E–20E
 55. Breugem CC, Bush K, Fitzpatrick DF (2007) Le Fort III rigid 
external distraction complicated by intracranial movement of 
halo fixation pins. Cleft Palate Craniofac J 45(3): 332–336
 56. Coeugniet E, Pellerin P, Wolber A, Dhellemmes P, Vinchon 
M. Fifteen years of experience with the midfacial distraction 
without maxillary osteotomy protocol. Childs Nerv Syst. (2014); 
30: 681–688.
 57. Guero S, Vassia L, Renier D, et al. Surgical management of the 
hand in Apert syndrome. Handchir Mikrochir Plast Chir. 2004; 
36: 179–185.
 58. Vargel I, Calis M, Cavusoglu T, Ekin O, Oznur A. Application 
of C-Shaped Osteotomy and Distraction Osteogenesis for 
Correction of Radial Angulation Deformities of the Hand 
in Children With Apert Syndrome: Review of 10 Years of 
Experience. Ann Plast Surg. (2014).
 59. Flatt AE. The care of congenital hand anomalies. 2nd ed. St. 
Louis: Quality Medical Publishing, 1994: 262–270.
 60. Upton J. Classification and pathologic anatomy of limb 
anomalies. Clin Plast Surg 1991; 18: 321–355.
 61. Van Heest AE, House JH., Recklin WC. Two-stage reconstruction 
of Apert acrosyndactyly. J. Hand Surg 1997; 22A: 315.
 62. Harvey I, Brown S, Ayres O, Proudman T. The Apert hand--
angiographic planning of a single-stage, 5-digit release for all 
classes of deformity. J Hand Surg Am. (2012); 37(1): 152-8.
 63. Chang J, Danton TK, Ladd AL, et al. Reconstruction of the hand 
in Apert syndrome: a simplified approach. Plast Reconstr Surg. 
2002; 109: 465–470; discussion 471.
 64. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome 
Biol 2: 3005.1–3005.12.
 65. Eswarakumar VP, Lax I, Schlessinger J. 2005. Cellular signaling 
by fibroblast growth factor receptors. Cytokine Growth Factor 
Rev 16: 139–149.
 66. Cohen MM, Jr., Kreiborg S. 1996. Suture formation, premature 
sutural fusion, and suture default zones in Apert syndrome. Am 
J Med Genet 62: 339–344.
 67. Suzuki H, Suda N, Shiga M, Kobayashi Y, Nakamura M, Iseki S, 
Moriyama K. Apert syndrome mutant FGFR2 and its soluble form 
reciprocally alter osteogenesis of primary calvarial osteoblasts. J 
Cell Physiol. 2012 Sep; 227(9): 3267-77.
 68. Chen L, Li D, Li C, Engel A, Deng CX. 2003. A Ser252Trp 
[corrected] substitution in mouse fibroblast growth factor 
receptor 2 (Fgfr2) results in craniosynostosis. Bone 33: 169–178.
 69. Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, 
Yang J, Jin M, Deng C, Chen L. 2008. A Pro253Arg mutation 
in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton 
malformation mimicking human Apert syndrome by affecting 
both chondrogenesis and osteogenesis. Bone 42: 631–643.
 70. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, 
Richtsmeier JT, Leszl JM, Hill CA, Yu K, Ornitz DM, Elisseeff J, 
Huso DL, Jabs EW. 2005. Abnormalities in cartilage and bone 
development in the Apert syndrome FGFR2(þ/S252W) mouse. 
Development 132: 3537–3548.
 71. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. 2007. 
RNA interference and inhibition of MEK-ERK signaling 
prevent abnormal skeletal phenotypes in a mouse model of 
craniosynostosis. Nat Genet 39: 1145–1150. 
 72. Holmes G. 2012. Mouse models of Apert syndrome. Childs Nerv 
Syst 28: 1505–1510.
InternatIonal archIves of MedIcIne
Section: cranio-Maxillofacial Surgery 
Issn: 1755-7682 
2015
Vol. 8 No. 87
doi: 10.3823/1686
© Under License of Creative Commons Attribution 3.0 License 11
 73. Tanimoto Y, Yokozeki M, Hiura K, Matsumoto K, Nakanishi H, 
Matsumoto T, Marie PJ, Moriyama K. 2004. A soluble form 
of fibroblast growth factor receptor 2 (FGFR2) with S252W 
mutation acts as an efficient inhibitor for the enhanced 
osteoblastic differentiation caused by FGFR2 activation in Apert 
syndrome. J Biol Chem 279: 45926–45934.
 74. Morita J, Nakamura M, Kobayashi Y, Deng CX, Funato N, 
Moriyama K. Soluble form of FGFR2 with S252W partially 
prevents craniosynostosis of the apert mouse model. Dev Dyn. 
2014 Apr; 243(4): 560-7.
 75. Yokota M, Kobayashi Y, Morita J, Suzuki H, Hashimoto Y, Sasaki 
Y, Akiyoshi K, Moriyama K. Therapeutic effect of nanogel-
based delivery of soluble FGFR2 with S252W mutation on 
craniosynostosis. PLoS One. 2014 Jul 8; 9(7): e101693.
 76. Johnson D, Wilkie AO (2011) Craniosynostosis. Eur J Hum Genet 
19: 369–376.
Where Doctors exchange clinical experiences,
review their cases and share clinical knowledge.
You can also access lots of medical publications for
free. Join Now!
http://medicalia.org/
Comment on this article:
International Archives of Medicine is an open access journal 
publishing articles encompassing all aspects of medical scien-
ce and clinical practice. IAM is considered a megajournal with 
independent sections on all areas of medicine. IAM is a really 
international journal with authors and board members from all 
around the world. The journal is widely indexed and classified 
Q1 in category Medicine.
Publish with iMedPub
http://www.imed.pub
